未登录

Z

Ziran Zhao

Cleveland Clinic Foundation

H指数:9

被引数:1,342

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs

NATURE COMMUNICATIONS

IF15.7

2024-07-100

OAAI

Co-stimulatory signaling boosts CAR T cell efficacy against chronic lymphocytic leukemia

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Challenges and opportunities of CAR T-cell therapies for CLL *

CLL的CAR T细胞疗法的挑战和机遇 *

SEMINARS IN HEMATOLOGY

IF4.1

2023-01-016

PRE

Single-cell antigen-specific landscape of CART infusion product identifies determinants of CD19-positive relapse in patients with ALL

SCIENCE ADVANCES

IF12.5

2022-06-1078

OAAI

The first Caribbean cell line, a prostate cancer cell line: ACRJ-PC28

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2022-01-010

PRE

PP2A/B55α substrate recruitment as defined by the retinoblastoma-related protein p107

IF0

2021-10-1818

PRE

Immortalization of human primary prostate epithelial cells via CRISPR inactivation of the CDKN2A locus and expression of telomerase

PROSTATE CANCER AND PROSTATIC DISEASES

IF5.8

2020-09-0117

OAAI

PPP2R2A prostate cancer haploinsufficiency is associated with worse prognosis and a high vulnerability to B55α/PP2A reconstitution that triggers centrosome destabilization

IF6.4

2019-12-1026

OAAI

Reconstituting B55/protein phosphatase 2A activity in B55/PP2A-defective prostate cancer cells suppresses proliferation and tumorigenicity through pleiotropic mechanisms

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Analysis of the tumor suppressor function of B55alpha, the PP2A regulatory subunit encoded by PPP2R2A, in prostate cancer cells

CANCER RESEARCH

IF16.6

2016-07-151

PRE